Search

everythinglearnresearchcommunity

for

Search:↓

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

High testosterone to epitestosterone ratio in hair could predict male-pattern baldness.

A 20-year-old woman was found to have a rare ovarian tumor causing symptoms like acne and a low-pitched voice, which disappeared after the tumor was removed.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Clinical exams are good for diagnosing some women's hair loss, but lab tests aren't always needed.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Chromosomal differences affect how muscle cells respond to testosterone.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Auto-portraits help evaluate scalp hair.

Autoimmune and inflammatory processes are involved in both scarring and non-scarring types of hair loss.

Women with excessive hair growth tend to have shorter index and ring fingers compared to others.

Spironolactone plus finasteride reduces hirsutism more effectively.